# 2024 AmCURE Antibiotic |
Antimicrobial resistance (AMR) poses a grave risk, potentially ushering in a “post-antibiotic era” where even minor infections could become deadly. Traditional antibiotics are losing efficacy, and new alternatives, like cationic polymers, show promise but face issues with in vivo toxicity. AmCURE addresses this by employing a “caging” strategy, where antimicrobials are deactivated and safely contained until reaching the infection site. This method releases the antimicrobials only in the presence of specific bacterial enzymes, reducing toxicity and enhancing treatment efficacy
Early detection and non-invasive correction of breech pregnancies